Education
About Us
Working with TipRanks
Follow Us
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H (HK:1558)
:1558
RESEARCH TOOLSreports
Total Valuation
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H has a market cap or net worth of HK$11.49B. The enterprise value is HK$20.21B.
Market CapHK$11.49B
Enterprise ValueHK$20.21B
Share Statistics
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H has 653,767,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding653,767,700
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 5.16%.
Return on Equity (ROE)0.06
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)5.16%
Return on Capital Employed (ROCE)0.07
Revenue Per Employee766.05K
Profits Per Employee118.75K
Employee Count4,861
Asset Turnover0.30
Inventory Turnover1.44
Valuation Ratios
The current PE Ratio of YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H is 16.37. YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H’s PEG ratio is 0.10.
PE Ratio16.37
PS Ratio0.00
PB Ratio4.53
Price to Fair Value0.93
Price to FCF16.38
Price to Operating Cash Flow11.12
PEG Ratio0.10
Income Statement
In the last 12 months, YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H had revenue of 3.72B and earned 482.71M in profits. Earnings per share was 0.55.
Revenue3.72B
Gross Profit2.79B
Operating Income674.47M
Pretax Income577.23M
Net Income482.71M
EBITDA1.05B
Earnings Per Share (EPS)0.55
Cash Flow
In the last 12 months, operating cash flow was 24.41M and capital expenditures -401.89M, giving a free cash flow of -377.49M billion.
Operating Cash Flow24.41M
Free Cash Flow-377.49M
Free Cash Flow per Share-0.58
Dividends & Yields
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H pays an annual dividend of HK$0.113, resulting in a dividend yield of ―
Dividend Per ShareHK$0.113
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.42
52-Week Price Change57.14%
50-Day Moving Average12.24
200-Day Moving Average10.14
Relative Strength Index (RSI)60.66
Average Volume (3m)7.69M
Important Dates
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H upcoming earnings date is Aug 22, 2025, TBA Not Confirmed.
Last Earnings DateMar 28, 2025
Next Earnings DateAug 22, 2025
Ex-Dividend DateSep 29, 2020
Financial Position
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H as a current ratio of 1.77, with Debt / Equity ratio of 68.85%
Current Ratio1.77
Quick Ratio1.54
Debt to Market Cap0.24
Net Debt to EBITDA0.79
Interest Coverage Ratio0.00
Taxes
In the past 12 months, YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H has paid 94.52M in taxes.
Income Tax94.52M
Effective Tax Rate0.16
Enterprise Valuation
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H EV to EBITDA ratio is 8.31, with an EV/FCF ratio of 0.00.
EV to Sales2.34
EV to EBITDA8.31
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H has HK$1.41B in cash and marketable securities with ¥2.23B in debt, giving a net cash position of HK$827.22M billion.
Cash & Marketable SecuritiesHK$1.41B
Total Debt¥2.23B
Net CashHK$827.22M
Net Cash Per ShareHK$1.27
Tangible Book Value Per ShareHK$8.29
Margins
Gross margin is 85.19%, with operating margin of 18.11%, and net profit margin of 12.96%.
Gross Margin85.19%
Operating Margin18.11%
Pretax Margin15.50%
Net Profit Margin12.96%
EBITDA Margin28.23%
EBIT Margin17.96%
Analyst Forecast
The average price target for YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H is HK$14.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetHK$14.00
Price Target Upside7.20% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-42.02%
EPS Growth Forecast-76.29%